Literature DB >> 5918615

Menstruation in women with normal or artificially controlled cycles.

G V Callard, F S Litofsky, L J DeMerre.   

Abstract

Entities:  

Keywords:  Bleeding; Clinical Research; Contraception; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Diseases; Ethinyl Estradiol--side effects; Family Planning; Medroxyprogesterone Acetate--side effects; Menstrual Cycle; Menstruation; Mestranol--side effects; Norethindrone Acetate--side effects; Norethindrone--side effects; Norethynodrel--side effects; Oral Contraceptives, Combined; Oral Contraceptives--side effects; Reproduction; Research Methodology; Signs And Symptoms

Mesh:

Substances:

Year:  1966        PMID: 5918615     DOI: 10.1016/s0015-0282(16)36070-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  4 in total

1.  Comparison of haematological indices between women of four ethnic groups and the effect of oral contraceptives.

Authors:  I F Godsland; M Seed; R Simpson; G Broom; V Wynn
Journal:  J Clin Pathol       Date:  1983-02       Impact factor: 3.411

Review 2.  Hormonal steroid contraceptives. I. Physiological and pharmacological considerations.

Authors:  R J Seddon
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 3.  Benefits and risks of pharmacological agents used for the treatment of menorrhagia.

Authors:  Samendra Nath Roy; Siladitya Bhattacharya
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  A simple and feasible questionnaire to estimate menstrual blood loss: relationship with hematological and gynecological parameters in young women.

Authors:  Laura Toxqui; Ana M Pérez-Granados; Ruth Blanco-Rojo; Ione Wright; M Pilar Vaquero
Journal:  BMC Womens Health       Date:  2014-05-30       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.